Welcome to our dedicated page for Inventiva S.A. SEC filings (Ticker: IVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inventiva S.A.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inventiva S.A.'s regulatory disclosures and financial reporting.
Schedule 13G filing: Great Point Partners, LLC ("Great Point"), along with Dr. Jeffrey R. Jay, M.D. and Ms. Lillian Nordahl, report a new 7.42 % passive stake in Inventiva S.A. (CUSIP F5R343107) as of 05 May 2025.
The group beneficially owns 10,576,827 ordinary shares, comprised of 7,243,495 shares held outright and warrants for 3,333,332 shares. The ownership calculation is based on 139,151,274 shares outstanding plus the warrant shares, as disclosed in Inventiva’s 6-K dated 05 May 2025.
- Great Point Partners, LLC is an investment adviser organised in Delaware and files as an IA/OO.
- Dr. Jay (Senior Managing Member) and Ms. Nordahl (Managing Director) each file as HC/IN with shared voting and dispositive power over the entire position; neither has sole power.
- The shares are held through two health-care–focused funds: Biomedical Value Fund, L.P. (4,853,356 shares + 2,166,666 warrants) and Biomedical Offshore Value Fund, Ltd. (2,390,139 shares + 1,166,666 warrants).
- The reporting persons expressly disclaim beneficial ownership except to the extent of their pecuniary interest.
No other material transactions, earnings data or strategic changes are disclosed. The filing is purely an ownership disclosure under Rule 13d-1(c), signalling that Great Point now exceeds the 5 % threshold and is required to report its passive investment in Inventiva.
FAQ
What is the current stock price of Inventiva S.A. (IVA)?
What is the market cap of Inventiva S.A. (IVA)?
